Ascentage Pharma Group International

AAPG | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.86

+$0.80 (+5.31%)

At close: Sep 21, 2026, 04:00 PM ET

$15.82

-$0.04 (-0.25%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	2.47B	1.24B	1.07B	1.48B	1.71B	1.02B
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	37.05M	33.86M	18.95M	18.53M	27.85M	31.77M
Other Long-Term Assets	30.74M	59M	10.05M	361.93M	35.88M	21.13M
Receivables	253.1M	99.07M	163.54M	61.49M	54.13M	480K
Inventory	28.64M	6.6M	16.17M	9.45M	3.93M	n/a
Other Current Assets	192.65M	24.63M	24.54M	16.6M	59.26M	17.31M
Total Current Assets	2.95B	1.47B	1.34B	1.64B	1.89B	1.08B
Property-Plant & Equipment	829.59M	905.86M	957.23M	650.03M	854.3M	477M
Goodwill & Intangibles	90.69M	100.69M	110.14M	109M	85.11M	122.09M
Total Long-Term Assets	1.02B	1.14B	1.16B	1.19B	1.05B	652M
Total Assets	3.97B	2.62B	2.5B	2.83B	2.94B	1.73B
Account Payables	106.81M	91.97M	72.45M	95.56M	70.86M	23.36M
Deferred Revenue	37.51M	54.09M	38.41M	24.35M	n/a	6.58K
Short-Term Debt	1.22B	769.62M	606.65M	510.31M	39.8M	44.75M
Other Current Liabilities	276.84M	n/a	n/a	2.82M	58.73M	16.87M
Total Current Liabilities	1.64B	1.17B	934.17M	881.15M	361.11M	276.15M
Long-Term Debt	742.8M	868.64M	1.17B	1.27B	1.03B	473.06M
Other Long-Term Liabilities	12.04M	6.27M	18.3M	35.33M	52.34M	73.57M
Total Long-Term Liabilities	986.62M	1.18B	1.5B	1.54B	1.34B	608.27M
Total Liabilities	2.63B	2.34B	2.43B	2.42B	1.71B	884.42M
Total Debt	1.98B	1.67B	1.8B	1.79B	1.08B	529.7M
Book Value	1.34B	274.16M	70.63M	408.66M	1.23B	846.62M
Book Value Per Share	15	3.63	4	24.80	77.59	62.74
Common Stock	256.16K	214K	197K	180K	178K	154K
Retained Earnings	n/a	-5.77B	-5.37B	-4.44B	-3.56B	-2.77B
Comprehensive Income	1.33B	-510.59M	-504.46M	-518.51M	-550.95M	-509.81M
Shareholders Equity	1.33B	264.19M	60.42M	408.66M	1.23B	846.62M
Total Investments	37.05M	33.86M	18.95M	18.53M	27.85M	31.77M